Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancer

被引：0
|
作者：
Ying Ma
Qin Feng
Bateer Han
Rong Yu
Zhiyong Jin
机构：
[1] Affiliated People’s Hospital of Inner Mongolia Medical University,Department of Thoracic Surgery
[2] Inner Mongolia Cancer Hospital and Affiliated People’s Hospital of Inner Mongolia Medical University,undefined
来源：
Hereditas | / 160卷
关键词：
High mobility group B1 (HMGB1); Non-small cell lung cancer (NSCLC); Cisplatin; Multidrug resistance (MDR);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancer
    Ma, Ying
    Feng, Qin
    Han, Bateer
    Yu, Rong
    Jin, Zhiyong
    [J]. HEREDITAS, 2023, 160 (01)
  • [2] Docetaxel Upregulates HMGB1 Levels in Non-small Cell Lung Cancer
    Haruna, Miya
    Hirata, Michinari
    Iwahori, Kota
    Kanazawa, Takayuki
    Yamamoto, Yoko
    Goto, Kumiko
    Kawashima, Atsunari
    Morimoto-Okazawa, Akiko
    Funaki, Soichiro
    Shintani, Yasushi
    Kumanogoh, Atsushi
    Wada, Hisashi
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2020, 43 (03) : 399 - 403
  • [3] Increased MALAT1 expression contributes to cisplatin resistance in non-small cell lung cancer
    Cui, Yong
    Li, Guanlong
    Zhang, Xin
    Dai, Fangfang
    Zhang, Rongxiang
    [J]. ONCOLOGY LETTERS, 2018, 16 (04) : 4821 - 4828
  • [4] LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis
    Qiu, Z.
    Pan, X. X.
    You, D. Y.
    [J]. NEOPLASMA, 2020, 67 (04) : 871 - 879
  • [5] The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer
    Feng, Anlin
    Tu, Zhenbo
    Yin, Bingjiao
    [J]. ONCOTARGET, 2016, 7 (15) : 20507 - 20519
  • [6] HMGB1-mediated Autophagy Promotes Gefitinib Resistance in Human Non-small Cell Lung Cancer
    Lei, T.
    Xu, T.
    Zou, X.
    Zhang, N.
    Wei, C.
    Wang, Z.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S620 - S620
  • [7] HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer
    Lei, Tianyao
    Huang, Jiali
    Xie, Fei
    Gu, Jingyao
    Cheng, Zhixiang
    Wang, Zhaoxia
    [J]. ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2022, 54 (04) : 514 - 523
  • [8] Methylmalonic acid is elevated in non-small cell lung cancer and promotes drug resistance
    Parang, Bobak
    Li, Zhongchi
    Low, Vivien
    Endress, Jennifer
    Malbari, Murtaza
    Saxena, Ashish
    Altorki, Nasser
    Blenis, John
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [9] HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer
    Gonzalez-Cao, Maria
    Cai, Xueting
    Bracht, Jilian Wilhelmina Paulina
    Han, Xuan
    Yang, Yang
    Pedraz-Valdunciel, Carlos
    Moran, Teresa
    Garcia-Corbacho, Javier
    Aguilar, Andres
    Bernabe, Reyes
    De Marchi, Pedro
    da Silva, Luciane Sussuchi
    Leal, Leticia Ferro
    Reis, Rui Manuel
    Codony-Servat, Jordi
    Jantus-Lewintre, Eloisa
    Molina-Vila, Miguel Angel
    Cao, Peng
    Rosell, Rafael
    [J]. LUNG CANCER-TARGETS AND THERAPY, 2024, 15 : 55 - 67
  • [10] Elevated HOTAIR expression associated with cisplatin resistance in non-small cell lung cancer patients
    Liu, Ming-Yue
    Li, Xi-Qing
    Gao, Tian-Hui
    Cui, Yao
    Ma, Ning
    Zhou, Yun
    Zhang, Guo-Jun
    [J]. JOURNAL OF THORACIC DISEASE, 2016, 8 (11) : 3314 - 3322
12345